ACQUIRED HAEMOPHILIA A
DOI:
https://doi.org/10.55519/JAMC-04-12289Keywords:
Acquired Haemophilia, inhibitor, bruising, bleeding, coagulation, mixing test, bethesda unitAbstract
Acquired haemophilia A (AHA) is a rare disease believed to be caused by spontaneous inhibition of clotting Factor VIII by autoantibodies. This is in contrast to the more common congenital haemophilias which are largely due to an absolute deficiency in coagulation factors. It has a prevalence of approximately one per million per year. However, this figure may be underestimated because there are many undocumented cases due to a lack of recognition. Patients who develop this disease may present with catastrophic bleeding despite having no previous bleeding history. In this study, we report a case of acquired Haemophilia A presenting with spontaneous unprovoked bruising and discuss the approach to diagnosis and how to alert the clinician to suspect this potentially rare but devastating disease.References
Yousphi AS, Bakhtiar A, Cheema MA, Nasim S, Ullah W. Acquired hemophilia A: A rare but potentially fatal bleeding disorder. Cureus 2019;11(8):e5442.
Ma AD, Carrizosa D. Acquired factor VIII inhibitors: pathophysiology and treatment. Hematology Am Soc Hematol Educ Program 2006;2006(1):432–7.
Mingot-Castellano ME, Rodríguez-Martorell FJ, Nuñez-Vázquez RJ, Marco P. Acquired haemophilia A: A review of what we know. J Blood Med 2022;13:691–710.
Knoebl P, Marco P, Baudo F, Collins P, Huth-Kühne A, Nemes L, et al. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2): Demographics of acquired hemophilia A. J Thromb Haemost 2012;10(4):622–31.
Pishko AM, Doshi BS. Acquired hemophilia A: Current guidance and experience from clinical practice. J Blood Med 2022;13:255–65.
Tiede A, Klamroth R, Scharf RE, Trappe RU, Holstein K, Huth-Kühne A, et al. Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study. Blood 2015;125(7):1091–7.
Haider MZ, Anwer F. Acquired Hemophilia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023.
Lossing TS, Kasper CK, Feinstein DI. Detection of factor VIII inhibitors with the partial thromboplastin time. Blood 1977;49(5):793–7.
Ewenstein BM. Nonhemophilic Inhibitors of Coagulation. In: Consultative Hemostasis and Thrombosis. Elsevier: 2007; p.81–95.
Tiede A, Collins P, Knoebl P, Teitel J, Kessler C, Shima M, et al. International recommendations on the diagnosis and treatment of acquired hemophilia A. Haematologica 2020;105(7):1791–801.
Knoebl P, Marco P, Baudo F, Collins P, Huth-Kühne A, Nemes L, et al. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2): Demographics of acquired hemophilia A. J Thromb Haemost [Internet]. 2012;10(4):622–31. Available from: http://dx.doi.org/10.1111/j.1538-7836.2012.04654.x
Pishko AM, Doshi BS. Acquired hemophilia A: Current guidance and experience from clinical practice. J Blood Med [Internet]. 2022;13:255–65. Available from: http://dx.doi.org/10.2147/JBM.S284804
Tiede A, Klamroth R, Scharf RE, Trappe RU, Holstein K, Huth-Kühne A, et al. Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study. Blood [Internet]. 2015;125(7):1091–7. Available from: http://dx.doi.org/10.1182/blood-2014-07-587089
Haider MZ, Anwer F. Acquired Hemophilia. StatPearls Publishing; 2022.
Lossing TS, Kasper CK, Feinstein DI. Detection of factor VIII inhibitors with the partial thromboplastin time. Blood [Internet]. 1977;49(5):793–7. Available from: http://dx.doi.org/10.1182/blood.v49.5.793.793
Ewenstein BM. Nonhemophilic Inhibitors of Coagulation. In: Consultative Hemostasis and Thrombosis. Elsevier; 2007. p. 81–95.
Tiede A, Collins P, Knoebl P, Teitel J, Kessler C, Shima M, et al. International recommendations on the diagnosis and treatment of acquired hemophilia A. Haematologica [Internet]. 2020;105(7):1791–801. Available from: http://dx.doi.org/10.3324/haematol.2019.230771
Additional Files
Published
Issue
Section
License
Copyright (c) 2023 Ewe Jin Koh, Jenq Tzong Tan, Nur Nadia Amalina Manan, Khai Yng Hor, Zi Yu Teh, Ming Lee Chin
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
